Browse by Aston Author

Tsatsakis, Aristidis M.; Nawaz, Muhammad Amjad; Tutelyan, Victor A.; Golokhvast, Kirill S.; Kalantzi, Olga-Ioanna; Chung, Duck Hwa; Kang, Sung Jo; Coleman, Michael D.; Tyshko, Nadia; Yang, Seung Hwan and Chung, Gyuhwa (2017). Impact on environment, ecosystem, diversity and health from culturing and using GMOs as feed and food. Food and Chemical Toxicology, 107 (part A), pp. 108-121.

Tarczyluk, Marta A.; Nagel, David A.; Parri, H. Rhein; Tse, Erin H.Y.; Brown, James E.; Coleman, Michael D. and Hill, Eric J. (2015). Amyloid β 1-42 induces hypometabolism in human stem cell-derived neuron and astrocyte networks. Journal of Cerebral Bood Fow and Metabolism, 35 (8), pp. 1348-1357.

Nagel, David A.; Hill, Eric J.; O'Neil, John; Mireur, Alexandra and Coleman, Michael D. (2014). The effects of the fungicides fenhexamid and myclobutanil on SH-SY5Y and U-251 MG human cell lines. Environmental Toxicology and Pharmacology, 38 (3), pp. 968-976.

Coleman, Michael D. (2014). Expert report writing in toxicology:forensic, scientific and legal aspects. Wiley-Blackwell.

Tarczyluk, Marta A.; Nagel, David A.; O'Neil, John; Parri, H. Rheinallt; Tse, Erin H.Y.; Coleman, Michael D. and Hill, Eric J. (2013). Functional astrocyte-neuron lactate shuttle in a human stem cell-derived neuronal network. Journal of Cerebral Bood Fow and Metabolism, 33 (9), pp. 1386-1393.

Coleman, Michael D. (2010). Human drug metabolism:an introduction. Wiley-Blackwell.

Holden, Lindsay J. and Coleman, Michael D. (2008). Further preliminary assessment of three human glioma cell lines as models of human astrocytic toxicity in vitro. Environmental Toxicology and Pharmacology, 26 (3), pp. 290-296.

Brown, Colin A.; Brown, Julia Y. and Coleman, Michael D. (2007). How drug metabolism influences treatment outcomes. Expert Opinion on Drug Metabolism and Toxicology, 3 (6), pp. 913-915.

Holden, Lindsay J. and Coleman, Michael D. (2007). Assessment of the astrogliotic responses of three human astrocytoma cell lines to ethanol, trimethyltin chloride and acrylamide. Toxicology, 241 (1-2), pp. 75-83.

Zilz, Thomas R.; Griffiths, Helen R. and Coleman, Michael D. (2007). Apoptotic and necrotic effects of hexanedione derivatives on the human neuroblastoma line SK-N-SH. Toxicology, 231 (2-3), pp. 210-214.

Coleman, Michael D.; Rimmer, Georgina S.E. and Haenen, Guido R.M.M. (2007). Effects of lipoic acid and dihydrolipoic acid on total erythrocytic thiols under conditions of restricted glucose in vitro. Basic and Clinical Pharmacology and Toxicology, 100 (2), pp. 139-144.

Woehrling, Elizabeth K.; Zilz, Thomas R. and Coleman, Michael D. (2006). The toxicity of hexanedione isomers in neural and astrocytic cell lines. Environmental Toxicology and Pharmacology, 22 (3), pp. 249-254.

Coleman, Michael D.; Williams, Charlotte and Haenen, Guido R.M.M. (2006). Effects of lipoic acid and dihydrolipoic acid on 4-aminophenol-mediated erythrocytic toxicity in vitro. Basic and Clinical Pharmacology and Toxicology, 99 (3), pp. 225-229.

Rathbone, Daniel L.; Parker, Katy J.; Coleman, Michael D.; Lambert, Peter A. and Billington, David C. (2006). Discovery of a potent phenolic N1-benzylidene- pyridinecarboxamidrazone selective against Gram-positive bacteria. Bioorganic and Medicinal Chemistry Letters, 16 (4), pp. 879-883.

Coleman, Michael D. (2006). Progress in the development of in vitro human-based alternatives to animal models. Environmental Toxicology and Pharmacology, 21 (2), pp. 120-122.

Coleman, Michael D.; Khan, Nazish; Welton, Graham; Lambert, Peter A.; Tims, Katy J. and Rathbone, Daniel L. (2004). Effects of glutathione, N-acetyl-cysteine, α-lipoic acid and dihydrolipoic acid on the cytotoxicity of a 2-pyridylcarboxamidrazone antimycobacterial agent in human mononuclear leucocytes in vitro. Environmental Toxicology and Pharmacology, 17 (3), pp. 143-148.

Coleman, Michael D.; Khalaf, Laila F. and Nicholls, Paul J. (2003). Aminoglutethimide-induced leucopenia in a mouse model:effects of metabolic and structural determinates. Environmental Toxicology and Pharmacology, 15 (1), pp. 27-32.

Coleman, Michael D.; Rathbone, Daniel L.; Chima, Rajinda; Lambert, Peter A. and Billington, David C. (2001). Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds III. Environmental Toxicology and Pharmacology, 9 (3), pp. 99-102.

Coleman, Michael D.; Rathbone, Daniel L.; Tims, Katie J.; Chima, Rajinda; Hovey, Melanie C.; Endersby, Catrina; Lee, Abberley and Billington, David C. (2000). Predictive toxicity studies on a set of antimycobacterial N′-benzylidene-heteroarylcarboxamidrazones. Journal of Pharmacy and Pharmacology, 52 (9 SUPP), p. 292.

Woehrling, Elizabeth K.; Hill, Eric J.; Nagel, David and Coleman, Michael D. Brain-derived neurotrophic factor as an indicator of chemical neurotoxicity:an animal-free CNS cell culture model. Alternatives to Laboratory Animals, 41 (6), pp. 503-511.

Ribeiro Schalcher, Taysa; Borges, Rosivaldo S.; Coleman, Michael D.; Júnior, João Batista; Salgado, Claudio G.; Vieira, Jose Luiz F.; Romão, Pedro R.T.; Oliveira, Fabio R. and Chagas Monteiro, Marta Clinical oxidative stress during leprosy multidrug therapy:impact of dapsone oxidation. PLoS ONE, 9 (1),

Veggi, Luis M.; Pretto, Luciana; Ochoa, Elena J.; Catania, Viviana A.; Luquita, Marcelo G.; Taborda, Diego R.; Sánchez Pozzi, Enrique J.; Ikushiro, Shin-ichi; Coleman, Michael D.; Roma, Marcelo G. and Mottino, Aldo D. Dapsone induces oxidative stress and impairs antioxidant defenses in rat liver. Life Sciences, 83 (5-6), pp. 155-163.

Coleman, Michael D. and Taylor, Clare T. Effects of dihydrolipoic acid (DHLA), α-lipoic acid. N-acetyl cysteine and ascorbate on xenobiotic-mediated methaemoglobin formation in human erythrocytes in vitro. Environmental Toxicology and Pharmacology, 14 (3), pp. 121-127.

Coleman, Michael D.; Aerry, R.; Wanogho, E.; Khan, N.B.; Lambert, Peter A. and Rathbone, Daniel L. Effects of glutathione and N-acetyl cysteine on the antimycobacterial efficacy of isoniazid on Mycobacterium fortuitum in vitro. Journal of Chemotherapy, 18 (6), pp. 665-666.

Coleman, Michael D. Improvement of patient tolerance to dapsone:current and future developments. Dermatology Online Journal, 13 (4),

Albuquerque, Rosyana V.; Malcher, Nívea S.; Amado, Lílian L.; Coleman, Michael D.; dos Santos, Danielle C.; Borges, Rosivaldo Sa.; Valente, Sebastião Aldo S.; Valente, Vera C. and Chagas Monteiro, Marta In vitro protective effect and antioxidant mechanism of Resveratrol induced by Dapsone Hydroxylamine in human cells. PLoS ONE, 10 (8),

Monteiro, Marta C.; Coleman, Michael D.; Hill, Eric J.; Prediger, Rui D. and Maia, Cristiane S.F. Neuroprotection in neurodegenerative disease:from basic science to clinical applications. Oxidative Medicine and Cellular Longevity, 2017 ,

Coleman, Michael D.; Zilz, Thomas R.; Griffiths, Helen R. and Woehrling, Elizabeth K. A comparison of the apoptotic and cytotoxic effects of hexanedione derivatives on human non-neuronal lines and the neuroblastoma line SH-SY5Y. Basic and Clinical Pharmacology and Toxicology, 102 (1), pp. 25-29.

Coleman, Michael D. and Holden, Lindsay J. The methaemoglobin forming and GSH depleting effects of dapsone and monoacetyl dapsone hydroxylamines in human diabetic and non-diabetic erythrocytes in vitro. Environmental Toxicology and Pharmacology, 17 (1), pp. 55-59.

Woehrling, Elizabeth K.; Parri, H. Rheinallt; Tse, Erin H.Y.; Hill, Eric J.; Maidment, Ian D.; Fox, G. Christopher and Coleman, Michael D. A predictive in vitro model of the impact of drugs with anticholinergic properties on human neuronal and astrocytic systems. PLoS ONE, 10 (3),

Coleman, Michael D.; Fernandes, Sandra and Khanderia, Leena A preliminary evaluation of a novel method to monitor a triple antioxidant combination (vitamins E, C and alpha-lipoic acid) in diabetic volunteers using in vitro methaemoglobin formation. Environmental Toxicology and Pharmacology, 14 (1-2), pp. 69-75.